|
|||||
|
|
Switching to insulin glargine 300 units/mL in real-world older patients with type 2 diabetes (DELIVER 3) |
|
| Authors: | Timothy S. Bailey MD Jasmanda Wu PhD Fang L. Zhou MD Rishab A. Gupta MTech Arjun A. Menon MBA Paulos Berhanu MD Jukka Westerbacka MD John Van Vleet PharmD Lawrence Blonde MD |
| Affiliation: | 1. AMCR Institute, Escondido, California;2. Department of Real-World Evidence & Clinical Outcomes, Sanofi, Bridgewater, New Jersey;3. Department of Applied Intelligence, Accenture, Florham Park, New Jersey;4. Department of US Medical Affairs, Sanofi, Bridgewater, New Jersey;5. Department of Global Medical Affairs, Sanofi, Paris, France;6. Frank Riddick Diabetes Institute, Endocrinology Department, Ochsner Medical Center, New Orleans, Louisiana |
| Abstract: | |
| Keywords: | hypoglycaemia insulin glargine 300 units/mL real-world study type 2 diabetes |